P Davis
Impact in
-
- Cancer-related Molecular Pathways
-
- Fibroblast Growth Factor Research
- Epigenetics and DNA Methylation
- TGF-β signaling in diseases
Papers in
- Oncology 3
- Cancer-related Molecular Pathways 3
-
- Fibroblast Growth Factor Research 1
- Co-authors
- Scott C. Robertson (1 shared paper)Melanie K. Webster (1 shared paper)Daniel J. Donoghue (1 shared paper)Jeffrey R. Marks (2 shared papers)J. Dirk Iglehart (2 shared papers)Laura J. Havrilesky (1 shared paper)Andrew Berchuck (1 shared paper)Robert C. Bast (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Molecular and Cellular Biology (1 paper)PubMed (5 papers)
- Partner nations
- United States
In The Last Decade
P Davis
7 papers receiving 355 citations
Peers
Comparison fields: 5 of 61
- Oncology 143
- Molecular Biology 288
- Genetics 91
- Biotechnology 23
- Cancer Research 37
Countries citing papers authored by P Davis
This map shows the geographic impact of P Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Davis more than expected).
Fields of papers citing papers by P Davis
This network shows the impact of papers produced by P Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Davis. The network helps show where P Davis may publish in the future.
Co-authors
The 17 scholars most cited alongside P Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 154 | |
| 2 | Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. | 1994 | 134 |
| 3 | 1995 | 47 | |
| 4 | The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity. | 1982 | 16 |
| 5 | Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells. | 1996 | 8 |
| 6 | Effect of gold salts on adherent mononuclear cells in tissue culture. | 1979 | 8 |
| 7 | In vivo and in vitro effects of gold salts on lymphocyte transformation responses and antibody dependent cell-mediated cytotoxicity. | 1980 | 7 |
About P Davis
P Davis is a scholar working on Oncology, Molecular Biology, Rheumatology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 7 papers that have together received 374 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Connective tissue disorders research (1 paper), Cancer Research and Treatments (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Fibroblast Growth Factor Research (1 paper), Traditional Chinese Medicine Analysis (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Oncology (143 citations), Molecular Biology (288 citations), Genetics (91 citations), Biotechnology (23 citations) and Cancer Research (37 citations). P Davis has collaborated with scholars based in United States. Frequent co-authors include Scott C. Robertson, Melanie K. Webster, Daniel J. Donoghue, Jeffrey R. Marks, J. Dirk Iglehart, Laura J. Havrilesky, Andrew Berchuck, Robert C. Bast, Russell As and James P. Vaughn. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.